Monthly information on share capital and company voting rights

Cellectis (CLLS) reported its monthly share capital and voting rights as of August 31, 2026, in line with Article 223-16 of the French financial markets authority.

Rhea-AI Summary

Cellectis (CLLS) reported its monthly share capital and voting rights as of August 31, 2026, in line with Article 223-16 of the French financial markets authority.

The company had 100,718,974 shares outstanding and a total of 105,568,956 voting rights on that date. The shares are listed on Euronext Growth under ISIN code FR0010425595.

Argus Sep 4 session 1 alert

-2.41% close to close 0.1x rel. volume Open Argus

Details

News Market Reaction – CLLS

$342.36M Mkt Cap at Peak Alert

On Sep 4, the first trading day after this news, CLLS closed 2.41% below the previous close.

Data tracked by StockTitan Argus for the Sep 4 session.

Key Figures

Disclosure date: 08/31/2026 Shares outstanding: 100,718,974 shares Total voting rights: 105,568,956 voting rights

Disclosure date

08/31/2026

Share-capital and voting-rights table

Shares outstanding

100,718,974 shares

As of 08/31/2026

Total voting rights

105,568,956 voting rights

As of 08/31/2026

Historical Context

5 past events · Latest: Sep 01

5 events

1. Sep 01

   Investor conference notice

   24h Move

   -1.5%

   Announced participation in healthcare investor conferences from September through November 2026.

2. Aug 06

   Second-quarter earnings

   24h Move

   +5.4%

   Reported clinical updates, financial results and cash resources for first-half 2026.

3. Aug 05

   Share-capital disclosure

   24h Move

   -3.6%

   Reported July 31 shares outstanding and total voting rights.

4. Jul 30

   Earnings date notice

   24h Move

   -3.5%

   Scheduled second-quarter 2026 results for August 6 after the U.S. market close.

5. Jul 02

   Share-capital disclosure

   24h Move

   -0.3%

   Reported June 30 shares outstanding and total voting rights.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

article 223-16, isin code

2 terms

article 223-16 regulatory

"Article 223-16 of General Regulation of the French financial markets authority"

Article 223-16 is a rule that requires certain financial firms, like banks and investment companies, to report their large or suspicious transactions to authorities. This helps prevent illegal activities such as money laundering or fraud, making the financial system safer and more transparent.

isin code financial

"Listing market: Euronext Growth ISIN code: FR0010425595"

An ISIN code is a unique identifier for a specific financial asset, like a stock or bond, similar to a product's barcode. It helps investors, traders, and banks quickly and accurately find and track that asset across different markets worldwide. This makes buying, selling, and managing investments more organized and reliable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Sept. 03, 2026 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

Date	Total number of shares in the capital	Total number of voting rights
08/31/2026	100,718,974	105,568,956

For further information on Cellectis, please contact:         

Media contacts:              
Pascalyne Wilson, Director, Communications, + 33 (0)7 76 99 14 33, media@cellectis.com  
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93      
    
Investor Relations contact:           
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com   

Attachment

• Voting_Rights_PR_August_2026_EN

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares does Cellectis (CLLS) have as of August 31, 2026?

As of August 31, 2026, Cellectis had a total of 100,718,974 shares in its share capital, as reported in its monthly disclosure under Article 223-16.

What is the total number of voting rights for Cellectis (CLLS) as of August 31, 2026?

Cellectis reported a total of 105,568,956 voting rights as of August 31, 2026. This figure reflects all voting rights attached to the company’s outstanding shares.

On which market and under which ISIN is Cellectis (CLLS) listed?

Cellectis shares are listed on Euronext Growth with ISIN code FR0010425595. The company publishes monthly information on its share capital and voting rights in line with French market regulations.

Why did Cellectis (CLLS) publish monthly information on share capital and voting rights?

Cellectis published the data to comply with Article 223-16 of the General Regulation of the French financial markets authority, which requires monthly disclosure of total shares in the capital and total voting rights.